Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
28.00
-0.10 (-0.36%)
Mar 31, 2025, 3:39 PM EDT - Market open
Palvella Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Palvella Therapeutics stock have an average target of 43.5, with a low estimate of 38 and a high estimate of 50. The average target predicts an increase of 55.36% from the current stock price of 28.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Palvella Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|
Strong Buy | 1 | 3 | 5 |
Buy | 0 | 0 | 1 |
Hold | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 1 | 3 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +60.71% | Mar 26, 2025 |
Jones Trading | Jones Trading | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +60.71% | Mar 25, 2025 |
Scotiabank | Scotiabank | Buy Initiates $50 | Buy | Initiates | $50 | +78.57% | Mar 7, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $39 | Strong Buy | Maintains | $39 | +39.29% | Feb 26, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +39.29% | Feb 20, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.64
from 0.67
EPS Next Year
-2.83
from -3.64
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 55,650 | n/a | n/a |
Avg | 17,513 | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -3.17 | -1.68 | -2.78 |
Avg | -3.64 | -2.83 | -3.12 |
Low | -4.28 | -3.85 | -4.04 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.